154 related articles for article (PubMed ID: 10413214)
1. Pulmonary hypertension secondary to systemic lupus erythematosus: prolonged survival following treatment with intermittent low dose iloprost.
Mok MY; Tse HF; Lau CS
Lupus; 1999; 8(4):328-31. PubMed ID: 10413214
[TBL] [Abstract][Full Text] [Related]
2. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
3. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
4. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension].
Andreassen AK; Madsen S; Kjekshus J; Simonsen S
Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1220-3. PubMed ID: 11402748
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
[TBL] [Abstract][Full Text] [Related]
6. Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease.
Hallioglu O; Dilber E; Celiker A
Am J Cardiol; 2003 Oct; 92(8):1007-9. PubMed ID: 14556887
[TBL] [Abstract][Full Text] [Related]
7. Aerosolized iloprost in CREST syndrome related pulmonary hypertension.
Launay D; Hachulla E; Hatron PY; Goullard L; Onimus T; Robin S; Fauchais AL; Queyrel V; Michon-Pasturel U; Hebbar M; Saulnier F; Devulder B
J Rheumatol; 2001 Oct; 28(10):2252-6. PubMed ID: 11669165
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of pulmonary hypertension with aerosolized iloprost.
Machherndl S; Kneussl M; Baumgartner H; Schneider B; Petkov V; Schenk P; Lang IM
Eur Respir J; 2001 Jan; 17(1):8-13. PubMed ID: 11307761
[TBL] [Abstract][Full Text] [Related]
9. Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.
Saiki C; Kashiwado Y; Yokoyama T; Ayano M; Imabayashi K; Kawano S; Higashioka K; Kimoto Y; Fukata M; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
Mod Rheumatol Case Rep; 2022 Jun; 6(2):183-188. PubMed ID: 35134204
[TBL] [Abstract][Full Text] [Related]
10. Intermittent epoprostenol infusions in systemic lupus erythematosus associated pulmonary hypertension--a series of three cases.
Kong KO; Badsha H; Thumboo J; Chng HH
Ann Acad Med Singap; 2003 Jan; 32(1):118-21. PubMed ID: 12625109
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery.
Yurtseven N; Karaca P; Uysal G; Ozkul V; Cimen S; Tuygun AK; Yuksek A; Canik S
Ann Thorac Cardiovasc Surg; 2006 Oct; 12(5):319-23. PubMed ID: 17095973
[TBL] [Abstract][Full Text] [Related]
12. Does cyclically iloprost infusion prevent severe isolated pulmonary hypertension in systemic sclerosis? Preliminary results.
Caramaschi P; Volpe A; Tinazzi I; Bambara LM; Carletto A; Biasi D
Rheumatol Int; 2006 Dec; 27(2):203-5. PubMed ID: 17006704
[TBL] [Abstract][Full Text] [Related]
13. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
[TBL] [Abstract][Full Text] [Related]
14. Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.
Ewert R; Opitz CF; Wensel R; Winkler J; Halank M; Felix SB
Clin Res Cardiol; 2007 Apr; 96(4):211-7. PubMed ID: 17294349
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study.
Kommireddy S; Bhyravavajhala S; Kurimeti K; Chennareddy S; Kanchinadham S; Rajendra Vara Prasad I; Rajasekhar L
Rheumatology (Oxford); 2015 Sep; 54(9):1673-9. PubMed ID: 25929760
[TBL] [Abstract][Full Text] [Related]
16. Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension.
Hoeper MM; Spiekerkoetter E; Westerkamp V; Gatzke R; Fabel H
Eur Respir J; 2002 Aug; 20(2):339-43. PubMed ID: 12212965
[TBL] [Abstract][Full Text] [Related]
17. Long term inhalation of iloprost in a child with primary pulmonary hypertension: an alternative to continuous infusion.
Beghetti M; Berner M; Rimensberger PC
Heart; 2001 Sep; 86(3):E10. PubMed ID: 11514501
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
[TBL] [Abstract][Full Text] [Related]
19. The effect of intravenous iloprost on pulmonary artery hypertension after paediatric congenital heart surgery.
Onan IS; Ozturk E; Yildiz O; Altin HF; Odemis E; Erek E
Interact Cardiovasc Thorac Surg; 2016 Feb; 22(2):194-9. PubMed ID: 26604214
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension.
Gessler T; Schmehl T; Hoeper MM; Rose F; Ghofrani HA; Olschewski H; Grimminger F; Seeger W
Eur Respir J; 2001 Jan; 17(1):14-9. PubMed ID: 11307743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]